TET2 mutation does not impact the prognosis of adult acute myeloid leukemia patients receiving a hematopoietic stem cell transplantation in first remission : similar outcome following matched sibling and unrelated versus haploidentical donor transplants in amulti-center retrospective analysis from the Global Committee and the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation
Source
Haematologica - ISSN 0390-6078-110:12 (2025) p. 3088-3093
Frequency and impact of somatic co-occurring mutations on post-transplant outcomes in acute myeloid leukemia : a multicenter registry analysis on behalf of the EBMT ALWP
Source
Bone marrow transplantation - ISSN 0268-3369- (2025) p.
Listeria monocytogenes infections in hematopoietic cell transplantation recipients : clinical manifestations and risk factors. A multinational retrospective case-control study from the Infectious Diseases Working Party of the European Society for Blood and Marrow Transplantation
Source
Transplantation and Cellular Therapy - ISSN 2666-6375-30:7 (2024) p. 1-12
Comparison of fludarabine/melphalan (FluMel) with fludarabine/melphalan/BCNU or thiotepa (FBM/FTM) in patients with AML in first complete remission undergoing allogeneic hematopoietic stem cell transplantation : a registry study on behalf of the EBMT Acute Leukemia Working Party
Source
Bone marrow transplantation - ISSN 0268-3369-59:2 (2024) p. 247-254
Treatment of primary plasma cell leukaemia with carfilzomib and lenalidomide-basedtherapy (EMN12/HOVON-129) : final analysis of a non-randomised, multicentre, phase 2 study
Source
The lancet oncology - ISSN 1470-2045-24:10 (2023) p. 1119-1133